IRCT201511217290N2已完成4 期
A primary evaluation of the effects of Atorvastatin on treatment-resistant obsessive compulsive disorder
Deputy for Reaserch and Techonology0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •resistant OCD (a patient should undergo continuous monotherapy treatment with SSRIs for three months in order to be defined as resistant); Signing inform consent.
- •Exclusion criteria: the patients did not have any innate neurological disorders, and laboratory test results for blood count; liver and renal functions were abnormal; a A minimum score of 21 in the Yale–Brown Scale (Y-BOCS) for OCD; breast feeding; pregnant women.
排除标准
- 未提供
研究者
相似试验
尚未招募
1 期
Atorvastatin and dexamethasone in adult patients with chronic subdural hematoma; Phase I-II.Chronic subdural hematomaRPCEC00000436Manuel Ascunce Domenech” University Hospital (HUMAD), in Camagüey48
招募中
不适用
Evaluation of the effect of Atorvastatin in diabetic type 2 patients in the morning and eveningIRCT20211211053359N1Babol University of Medical Sciences76
已完成
3 期
Study of the effect of statins on migrainemigraine headaches.MigraineIRCT20190620043953N2Yazd University of Medical Sciences60
招募中
3 期
The effect of atorvastatin in the prevention of gastrointestinal toxicity in patients undergoing pelvic radiotherapyIRCT20200825048515N36Esfahan University of Medical Sciences64
招募中
3 期
Effect of Atorvastatin in the management of COVID-19COVID-19.Coronavirus infection, unspecifiedB34.2IRCT20150221021159N7Esfahan University of Medical Sciences60